(Total Views: 476)
Posted On: 02/06/2021 8:41:45 PM
Post# of 154118
Beta Amyloid 2: Tau-lectric Boogaloo
Quote:
The antibody targets aggregated forms of β-amyloid found in the brains of people with Alzheimer's disease, in the hopes of reducing its buildup.[3] Biogen halted development of the drug in March 2019 after preliminary data from two phase III trials suggested it would not meet the primary endpoint.[4][5][6]
(1)
(0)
